拓爾思(300229.SZ):擬轉讓耐特康賽10%股權
格隆匯 12 月 15日丨拓爾思(300229.SZ)公佈,為優化子公司股權治理結構,提高管理運營效率,公司擬向渠成轉讓公司持有的控股子公司耐特康賽網絡技術(北京)有限公司(“耐特康賽”)10%股權,轉讓價格為1200萬元。此次股權轉讓完成後,公司仍持有耐特康賽45%股權,耐特康賽將不再納入公司合併報表範圍。
根據企業會計準則的相關核算方法,公司以2020年9月30日為基準日進行初步測算,此次股權轉讓如在2020年度完成,預計對合並報表損益的影響金額約為-4769.46萬元,最終數據將以公司經審計的財務報告數據為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.